“Additionally, both paw oedema and contraction of portal vein mediated by B1 agonist des‐Arg9‐BK in ADX rats, were markedly inhibited by treatment with dexamethasone , or COX‐2 inhibitor meloxican, or with the NF‐κB inhibitor PDTC.”
“It was also confirmed that the treatment of ADX rats with dexamethasone, PDTC or dexamethasone plus PDTC completely inhibit NF‐κB activation caused by absence of endogenous glucucorticoid.”